Bulletin
Investor Alert

Eli Lilly & Co.

NYS: LLY

GO
/marketstate/country/us

After Hours

LLY
/zigman2/quotes/200106384/composite

$

188.60

Change

-0.65 -0.34%

Volume

Volume 98,104

Apr 16, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200106384/composite

Previous close

$ 185.92

$ 189.25

Change

+3.33 +1.79%

Day low

Day high

$186.88

$190.30

Open
Open: 187.38

52 week low

52 week high

$129.21

$218.00

Open

Market cap

$178.19B

Average volume

3.50M

P/E ratio

27.86

Rev. per Employee

$701,137

EPS

6.79

Dividend

0.85

Div yield

1.80%

Ex dividend date

2/11/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lly

MarketWatch News on LLY

  1. Lilly expects combination to be better in dealing with COVID variants than bamlanivimab alone

    6:33 a.m. April 16, 2021

    - Ciara Linnane

  2. Lilly is seeking an EUA for bamlanivimab and etesevimab together as US COVID treatment

    6:33 a.m. April 16, 2021

    - Ciara Linnane

  3. Eli Lilly requests revocation of emergency use authorization for bamlanivimab alone as COVID treatment

    6:32 a.m. April 16, 2021

    - Ciara Linnane

  4. Lilly and Incyte say trial data showed 38% reduction in mortality by Day 28 for baricitinib plus SOC

    6:48 a.m. April 8, 2021

    - Ciara Linnane

  5. Eli Lilly and Incyte say results of Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal

    6:48 a.m. April 8, 2021

    - Ciara Linnane

  6. Lilly, Vir and Glaxo say combined monoclonal antibodies found 70% reduction in high viral load at day 7

    8:33 a.m. March 29, 2021

    - Ciara Linnane

  7. Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment

    8:33 a.m. March 29, 2021

    - Ciara Linnane

  8. GSK and Vir Submit Covid-19 Drug for FDA Authorization

    9:49 a.m. March 26, 2021

    - Josh Nathan-Kazis

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/lly

Other News on LLY

  1. 1 Cancer Stock to Buy and Hold for the Next Decade

    6:32 a.m. April 17, 2021

    - Motley Fool

  2. Lilly Ends U.S. Use of Single Covid-19 Antibody Drug Alone

    5:39 p.m. April 16, 2021

    - Peter Loftus

  3. Merck hurt by another setback in its battle against COVID-19

    1:39 p.m. April 15, 2021

    - Seeking Alpha

  4. Merck Halts Covid-19 Treatment Trial for Hospitalized Patients

    6:46 a.m. April 15, 2021

    - Jared S. Hopkins

  5. Drugmakers Are Vying for a Multibillion-Dollar Market

    8:05 a.m. April 14, 2021

    - Motley Fool

  6. Should AbbVie Be Worried About Rinvoq?

    7:01 a.m. April 14, 2021

    - Motley Fool

  7. March Mailbag: Invest Like a Girl

    7:38 p.m. April 13, 2021

    - Motley Fool

  8. A Short Delay Is Still Bad News for AbbVie

    8:02 a.m. April 13, 2021

    - Motley Fool

  9. Wall Street Breakfast: Inflation Sticker Shock

    7:02 a.m. April 13, 2021

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/lly

Press Releases on LLY

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.